Spotlight On
鈥� Despite its name, non-transfusion-dependent thalassemia is not a mild form of the disease
Latest in Spotlight On
High levels of immune infiltrates are strongly prognostic for favorable outcomes
Patients are living longer, highlighting the need for an effective transition
Gene therapy is also emerging as a promising alternative
Two large trials, real-world data inform clinical decision-making
Gene therapy is also emerging as a promising alternative
Two large trials, real-world data inform clinical decision-making
More in Spotlight On
Fatigue seems to have the biggest negative impact on patients' quality of life, experts say
Often, supportive care is the only option
Newest EGFR TKIs have changed the game for treating asymptomatic brain metastases
Key innovations from the ASH annual meeting
Uveitis, psoriasis, IBD are common
One notable study showed improved survival with trastuzumab deruxtecan
But the best strategy for stage I disease is less clear, experts say
Challenges include identifying high-risk patients and optimizing therapy
Transformation occurs in a minority of patients, with an extremely poor prognosis
"It is really a discussion of their individual health conditions," one expert says
Two new drugs offer promise after obeticholic acid misses out on full approval
Disease chronicity and progression raise ongoing questions
More research needed on role of local therapy in new era of treatment
Balancing risk and benefit takes a personal approach with frailty scores, clinical assessments
